Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: FAP PET/CT for Staging Patients With Breast Cancer [Phase 2]
A Phase 2 clinical trial is exploring FAP PET/CT imaging to stage patients with breast cancer; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Peer Support For Young Adult Women With High Breast Cancer Risk [NA]
Georgetown University is conducting a clinical trial on peer support for young adult women at high risk of breast cancer, and the study is c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer
A clinical trial update describes ongoing evaluation of evidence-based chemotherapy use in endocrine-sensitive breast cancer. The study is c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]
IAM1363 is being studied in a Phase 1/1b trial for HER2-related cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer [Phase 1]
A Phase 1 clinical trial update indicates Boundless Bio is recruiting participants for BBI-940, an oral kinesin degrader, in advanced or met…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Biomarkers to Detect Endocrine Therapy Resistance [Phase 2]
A Phase 2 clinical trial update focused on identifying biomarkers to detect resistance to endocrine therapy in metastatic breast cancer, inc…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase IIa Study to Evaluate NBQ72S [Phase 2]
A Phase IIa study to evaluate NBQ72S in breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of HLD-0117 in Patients With Metastatic Breast Cancer [Phase 1]
This clinical trial update indicates that a Phase 1 study of HLD-0117 for metastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer [NA]
A clinical trial is evaluating spa therapy to assess its potential benefit on radiation-induced fibrosis in patients with breast cancer or h…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ribociclib for HR-positive, HER2-negative metastatic breast cancer is currently recruiting, sponsored …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Oral Aromatase Inhibitors Modify the Gut Microbiome
A clinical trial is recruiting to study whether oral aromatase inhibitors affect the gut microbiome in breast cancer patients.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer. [Phase 1]
This is a first-in-human Phase 1 clinical trial to assess the safety of ES2B-C001-S01 (with or without adjuvant) in patients with HER2-expre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies [Phase 2]
A Phase 2 trial update from UNC Lineberger Comprehensive Cancer Center for biomarker-driven therapies in breast cancer, currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer
This clinical trial update outlines a study that uses patient-derived organoids to functionally characterize chemotherapy resistance in brea…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer [Phase 1]
Phase 1 neoadjuvant trial evaluating DPX-Survivac with an aromatase inhibitor, radiotherapy, or cyclophosphamide in hormone receptor-positiv…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer [Phase 1, Phase 2]
Hoffmann-La Roche is conducting a Phase 1/2 study to evaluate the safety and efficacy of multiple treatment combinations in patients with es…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Prospective Surveillance for Breast Cancer-Related Lymphedema [NA]
Clinical trial update for a prospective surveillance of breast cancer-related lymphedema. Sponsored by Rigshospitalet in Denmark, the study …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Exercise Training in Women With Metastatic Breast Cancer [NA]
Clinical trial update about exercise training for women with metastatic breast cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients [Phase 2]
Phase 2 trial of nivolumab, ipilimumab, and bicalutamide for HER2-negative breast cancer is active and not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer
This clinical trial update evaluates the diagnostic performance of 18F-FDG PET/CT to detect distant metastases in locally advanced or metast…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients [NA]
A clinical trial is recruiting to evaluate telenursing for early detection and management of side effects in breast cancer patients treated …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates [Phase 2]
A multicenter, single-arm Phase II exploratory trial evaluating eribulin plus anlotinib for HER2-negative recurrent/metastatic breast cancer…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. [Phase 2]
A Phase 2 trial at UC San Diego is exploring AI/ML-guided rechallenge with CDK4/6 inhibitors for breast cancer, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI. [Phase 4]
An ongoing Phase 4 trial is examining whether body mass index influences the plasma exposure of the trastuzumab deruxtecan payload (Free-DXd…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer [NA]
A clinical trial is evaluating the efficacy of a novel probiotic on the bacteriome and mycobiome in breast cancer patients. The study is cur…